Design, Synthesis and Cytotoxicity Screening of New Thiazole Derivatives as Potential Anticancer Agents through VEGFR-2 Inhibition

被引:11
作者
Al-Warhi, Tarfah [1 ]
Abualnaja, Matokah [2 ]
Abu Ali, Ola A. [3 ]
Alyamani, Najiah M. [4 ]
Elsaid, Fahmy G. [5 ,6 ]
Shati, Ali A. [5 ]
Albogami, Sarah [7 ]
Fayad, Eman [7 ]
Abu Almaaty, Ali H. [8 ]
Mohamed, Khaled O. [9 ]
Alamoudi, Wael M. [10 ]
Zaki, Islam [11 ]
机构
[1] Princess Nourah Bint Abdulrahman Univ, Coll Sci, Dept Chem, POB 84428, Riyadh 11671, Saudi Arabia
[2] Umm Al Qura Univ, Fac Appl Sci, Dept Chem, Makkah Al Mukarrama 24381, Saudi Arabia
[3] Taif Univ, Coll Sci, Dept Chem, POB 11099, Taif 21944, Saudi Arabia
[4] Univ Jeddah, Coll Sci, Biol Dept, Jeddah 23218, Saudi Arabia
[5] King Khalid Univ, Coll Sci, Biol Dept, Abha 61421, Saudi Arabia
[6] Mansoura Univ, Fac Sci, Zool Dept, Mansoura 35516, Egypt
[7] Taif Univ, Fac Sci, Dept Biotechnol, POB 11099, Taif 21944, Saudi Arabia
[8] Port Said Univ, Fac Sci, Zool Dept, Port Said 42526, Egypt
[9] Cairo Univ, Fac Pharm, Pharmaceut Organ Chem Dept, Cairo 11562, Egypt
[10] Umm Al Qura Univ, Fac Appl Sci, Dept Biol, Makkah Al Mukarrama 24382, Saudi Arabia
[11] Port Said Univ, Fac Pharm, Pharmaceut Organ Chem Dept, Port Said 42526, Egypt
来源
SYMMETRY-BASEL | 2022年 / 14卷 / 09期
关键词
Z-configurated isomers; thiazole; hydrazinecarbothioamide; phenacylbromide; cytotoxicity; VEGFR-2; apoptosis; p53; mitochondrial membrane potential (MMP);
D O I
10.3390/sym14091814
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Z-configurated isomers are kinetically preferred molecules. Compounds with Z-configuration are contained in many natural products, biologically active compounds and as synthons for organic synthesis. Two series of new thiazole-based analogs were synthesized from appropriate starting materials hydrazinecarbothioamide derivatives (Z)-2a,b to be evaluated for their inhibitory activity towards VEGFR-2. The prepared thiazole compounds 3a-5b were screened for their cytotoxic potency against the MDA-MB-231 breast cancer cell line and their percentage inhibition against VEGFR-2. Compound 4d exhibited good VEGFR-2 inhibitory activity. A DNA flow cytometry analysis was conducted, and compound 4d demonstrated cell cycle arrest at the G1 and G2/M phases of the cell cycle profile and an apoptosis-inducing effect by increasing the percentage of pre-G1 phase. Compound 4d was further evaluated for its apoptosis-inducing effect by studying the effect on mitochondrial membrane potential (MMP) and p53 activation. It was found to boost the level of p53 and reduce the level of MMP compared with the untreated control cells.
引用
收藏
页数:16
相关论文
共 37 条
  • [1] Natural Products for Cancer Therapy: A Review of Their Mechanism of Actions and Toxicity in the Past Decade
    Abdalla, Yasir Osman Ali
    Subramaniam, Bavani
    Nyamathulla, Shaik
    Shamsuddin, Noorasyikin
    Arshad, Norhafiza M.
    Mun, Kein Seong
    Awang, Khalijah
    Nagoor, Noor Hasima
    [J]. JOURNAL OF TROPICAL MEDICINE, 2022, 2022
  • [2] New Series of VEGFR-2 Inhibitors and Apoptosis Enhancers: Design, Synthesis and Biological Evaluation
    Abdallah, Abdallah E.
    Mabrouk, Reda R.
    Elnagar, Mohamed R.
    Farrag, Amel Mostafa
    Kalaba, Mohamed H.
    Sharaf, Mohamed H.
    El-Fakharany, Esmail M.
    Bakhotmah, Dina Abed
    Elkaeed, Eslam B.
    Al Ward, Maged Mohammed Saleh
    [J]. DRUG DESIGN DEVELOPMENT AND THERAPY, 2022, 16 : 587 - 606
  • [3] New pyrimidine/thiazole hybrids endowed with analgesic, anti-inflammatory, and lower cardiotoxic activities: Design, synthesis, and COX-2/sEH dual inhibition
    Abdel-Aziz, Salah A.
    Taher, Ehab S.
    Lan, Ping
    El-Koussi, Nawal A.
    Salem, Ola I. A.
    Gomaa, Hesham A. M.
    Youssif, Bahaa G. M.
    [J]. ARCHIV DER PHARMAZIE, 2022, 355 (07)
  • [4] Selective VEGFR-2 inhibitors: Synthesis of pyridine derivatives, cytotoxicity and apoptosis induction profiling
    AbdelHaleem, Amal
    Mansour, Amira O.
    AbdelKader, Marwa
    Arafa, Reem K.
    [J]. BIOORGANIC CHEMISTRY, 2020, 103
  • [5] Design, synthesis, and screening of ortho-amino thiophene carboxamide derivatives on hepatocellular carcinomaas VEGFR-2Inhibitors
    AbdElhameid, Mohammed K.
    Labib, Madlen B.
    Negmeldin, Ahmed T.
    Al-Shorbagy, Muhammad
    Mohammed, Manal R.
    [J]. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2018, 33 (01) : 1472 - 1493
  • [6] Molecular Pathogenesis of Colorectal Cancer with an Emphasis on Recent Advances in Biomarkers, as Well as Nanotechnology-Based Diagnostic and Therapeutic Approaches
    Al-Joufi, Fakhria A.
    Setia, Aseem
    Salem-Bekhit, Mounir M.
    Sahu, Ram Kumar
    Alqahtani, Fulwah Y.
    Widyowati, Retno
    Aleanizy, Fadilah Sfouq
    [J]. NANOMATERIALS, 2022, 12 (01)
  • [7] Design, Synthesis, and Evaluation of a New Series of Thiazole-Based Anticancer Agents as Potent Akt Inhibitors
    Altintop, Mehlika Dilek
    Sever, Belgin
    Ciftci, Gulsen Akalin
    Ozdemir, Ahmet
    [J]. MOLECULES, 2018, 23 (06):
  • [8] Thiazole: A Versatile Standalone Moiety Contributing to the Development of Various Drugs and Biologically Active Agents
    Arshad, Mohammed F.
    Alam, Aftab
    Alshammari, Abdullah Ayed
    Alhazza, Mohammed Bader
    Alzimam, Ibrahim Mohammed
    Alam, Md Anish
    Mustafa, Gulam
    Ansari, Md Salahuddin
    Alotaibi, Abdulelah M.
    Alotaibi, Abdullah A.
    Kumar, Suresh
    Asdaq, Syed Mohammed Basheeruddin
    Imran, Mohd
    Deb, Pran Kishore
    Venugopala, Katharigatta N.
    Jomah, Shahamah
    [J]. MOLECULES, 2022, 27 (13):
  • [9] Polyphenols inhibiting MAPK signalling pathway mediated oxidative stress and inflammation in depression
    Behl, Tapan
    Rana, Tarapati
    Alotaibi, Ghallab H.
    Shamsuzzaman, Md
    Naqvi, Maaz
    Sehgal, Aayush
    Singh, Sukhbir
    Sharma, Neelam
    Almoshari, Yosif
    Abdellatif, Ahmed A. H.
    Iqbal, Muhammad Shahid
    Bhatia, Saurabh
    Al-Harrasi, Ahmed
    Bungau, Simona
    [J]. BIOMEDICINE & PHARMACOTHERAPY, 2022, 146
  • [10] Aromatase inhibitors versus tamoxifen in premenopausal women with oestrogen receptor-positive early-stage breast cancer treated with ovarian suppression: a patient-level meta-analysis of 7030 women from four randomised trials
    Bradley, R.
    Braybrooke, J.
    Gray, R.
    Hills, R. K.
    Liu, Z.
    Pan, H.
    Peto, R.
    Dodwell, D.
    McGale, P.
    Taylor, C.
    Bergh, J.
    Swain, S.
    Francis, P. A.
    Gnant, M.
    Perrone, F.
    Regan, M. M.
    [J]. LANCET ONCOLOGY, 2022, 23 (03) : 382 - 392